Global Candida Auris Infection Market, By Treatment (Antifungal Drugs, Others), Diagnosis (Blood Tests, Laboratory Tests, Others), Dosage (Tablet, Injection, Others), Route of Administration (Oral, Intravenous, Others), Symptoms (Fever, Chills, Sepsis, Others), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028.
Market Analysis and Insights: Global Candida Auris Infection Market
Candida auris infection market is expected to gain market growth in the forecast period of 2021-2028. Data Bridge Market Research analyses the market to account to grow at a CAGR of 4.60% in the above mentioned forecast period.
Candida auris is defined as a type of yeast that causes wound, bloodstream and ear infection. It can affect people of any age and can also lead to candidiasis. It lives on the skin and inside the human body. Common symptoms of this condition are fever, chills, sepsis and others.
Rise in the prevalence of diabetes and high consumption of antibiotics are the major factors influencing the market growth rate. Furthermore, growing healthcare expenditure, growing government funding and rising initiatives by government and private organizations to spread awareness about the disease and its preventive measures are the factors that will expand the candida auris infection market.
Rise in the research and development activities and emerging markets will provide beneficial opportunities for the candida auris infection market in the forecast period of 2021-2028.
However, high cost of treatment and side effects associated with the treatment are the factors that will hinder the market growth. In the forecast period mentioned above, lack of awareness about the preventive measures will further challenge the candida auris infection market.
This candida auris infection market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the candida auris infection market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Candida Auris Infection Market Scope and Market Size
The candida auris infection market is segmented on the basis of treatment, diagnosis, dosage, route of administration, symptoms, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of treatment, the candida auris infection market is segmented into antifungal drugs and others. Antifungal drugs have been further sub-segmented into echinocandins.
- On the basis of diagnosis, the candida auris infection market is segmented into blood tests, laboratory tests and others.
- On the basis of dosage, the candida auris infection market is segmented into tablet, injection and others.
- On the basis of route of administration, the candida auris infection market is segmented into oral, intravenous and others.
- On the basis of symptoms, the candida auris infection market is segmented into fever, chills, sepsis and others.
- On the basis of end-users, the candida auris infection market is segmented into clinic, hospital and others.
The candida auris infection market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.
Candida Auris Infection Market Country Level Analysis
The candida auris infection market is segmented on the basis of treatment, diagnosis, dosage, route of administration, symptoms, end-users and distribution channel.
The countries covered in the candida auris infection market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.
North America dominates the candida auris infection market due to major key players, high disposable income, high healthcare expenditure and well-developed healthcare sector in this region. Asia-Pacific is expected to grow during the forecast period of 2021-2028 due to the increasing research and development activities, rising investment in the healthcare sector and growing government support.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
Candida auris infection market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Global Candida Auris Infection Market Share Analysis
Candida auris infection market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to global candida auris infection market research.
The major players covered in the candida auris infection market report are Merck Sharp & Dohme Corp., Pfizer Inc., GlaxoSmithKline plc, Bayer AG, Sun Pharmaceutical Industries Ltd., Sanofi, Novartis AG, Glenmark Pharmaceuticals Limited, Abbott, Astellas Pharma Inc., Gilead Sciences, Inc., Enzon Pharmaceuticals, Inc., SCYNEXIS, Inc., Merck KGaA, Leadiant Biosciences, Inc., Bausch Health Companies Inc., Beckman Coulter, Inc., Basilea Pharmaceutica Ltd., Agilent Technologies, Inc., among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-